Immagini fornite dal libraio
Our orders are sent from our warehouse locally or directly from our international distributors to allow us to offer you the best possible price and delivery time. Codice inventario libreria
Riassunto: The pharmaceutical industry has long and vehemently insisted that it has the willingness, the dedication, and the ability to police itself to insure that the public will not be unnecessarily harmed or defrauded. As the record shows with painful clarity, however, virtually no industry or professional group has ever adequately policed itself, and the pharmaceutical industry is no exception. Where the most flagrant abuses have been exposed and corrected, major credit must probably be divided among the media that publicized the situation, consumer groups that applied pressure, government officials who took actions that were often unpopular, and individual members of the pharmaceutical industry who had the courage to face up to their social responsibilities.
In this book, the authors turn their attention to what happened in Third World countries when, because of worldwide pressures, the multinational drug companies largely corrected their notorious abuses. On the basis of painstaking research, much of it conducted in a great many Third World countries, the authors conclude that a plethora of small local firms have filled the dishonest sales channels vacated by the multinationals. The authors show in great detail how local drug firms in the Third World have taken advantage of loose regulatory practices and unscrupulous behavior on the part of regional and national health care professionals to promote the sale of dangerous or worthless drugs as remedies for diseases for which they were never intended. Warnings of bad side effects are omitted from promotional literature, drugs are sold that have not had proper trials, and drug firms have often bribed government officials, doctors, and hospital administrators in order to gain favorable treatment in the importation and sale of their products. Among the many topics treated in this book are the controversy over inexpensive generic drugs (including disclosures of fraud and bribery in the U.S. Food and Drug Administration), the actions of consumer groups, and the key role of government in preventing abuses by drug firms. The authors describe a remarkable attempt in Bangladesh, one of the poorest of all the developing countries, to develop a high-quality local drug industry. They also present as case histories reports on three extremely important drug products or groups―the dipyrones (for control of pain and fever), high-dosage estrogen-progesterone hormone products (for use in pregnancy tests), and clioquinol or Enterovioform (for treatment of diarrhea)―all of which were or still are centers of worldwide, heated controversy.
From Kirkus Reviews: Silverman, Lydecker, and Lee--who took upon themselves the seemingly Sisyphean task of exposing the abuses of the pharmaceutical industry (Prescriptions for Death: The Drugging of the Third World, 1982, etc.)--now reexamine the situation in the Third World and conclude that a worldwide crisis exists. The present survey, begun in 1987, indicates that most multinational drug companies, under pressure from within and without, have improved the way they label and market their products. But apparently the public hasn't benefited--for, the authors contend, scores of useless and dangerous drugs are now put out by local or domestic firms, small in size but large in political clout. Fraudulent drugs abound, and badly needed ones are unavailable. The authors cite some small success stories- -India's ban on deadly, high-dosage hormones, and a pilot project in Gambia in which drug companies and the government cooperated to set up a drug-distribution system--but they observe that, in most developing nations, drug-regulation agencies are corrupt, weak, and underfunded, and their workers poorly trained. Bribery, the authors note, is a way of life throughout the Third World. They conclude that what's needed is constant surveillance, as well as continuous consultation among consumer advocates, the drug industry, government agencies, and the medical and pharmacy professions, with the World Health Organization leading the way. The scrutiny is close, the research impressive, though the presentation is so detailed that it may overwhelm all but the most concerned reader. Still, a thorough assessment of a perilous situation. -- Copyright ©1992, Kirkus Associates, LP. All rights reserved.
Titolo: Bad Medicine
Casa editrice: Stanford University Press
Data di pubblicazione: 1992
Condizione libro: New
Descrizione libro Stanford University Press. Hardcover. Condizione libro: GOOD. Spine creases, wear to binding and pages from reading. May contain limited notes, underlining or highlighting that does affect the text. Possible ex library copy, thatâ€™ll have the markings and stickers associated from the library. Accessories such as CD, codes, toys, may not be included. Codice libro della libreria 2561265892
Descrizione libro Stanford University Press, 1992. Condizione libro: Good. 1st Edition. Shows some signs of wear, and may have some markings on the inside. Codice libro della libreria GRP62913178
Descrizione libro Stanford University Press, 1992. Condizione libro: Good. 1st Edition. Former Library book. Shows some signs of wear, and may have some markings on the inside. Codice libro della libreria GRP10812241
Descrizione libro Stanford University Press, 1992. Hardcover. Condizione libro: Used: Good. Codice libro della libreria SONG0804716692
Descrizione libro Stanford University Press. Condizione libro: Good. 0804716692 Ex-library hardcover with stickers, pocket and markings. Some wear to cover and pages. Binding is tight, text is clean. New plastic cover. Good reading copy. USPS tracking number provided for US orders. Codice libro della libreria SKU1009745
Descrizione libro Stanford University Press, 1992. Hardcover. Condizione libro: New. book. Codice libro della libreria M0804716692
Descrizione libro Condizione libro: Good. Bad Medicine: The Prescription Drug Industry in the Third World. Codice libro della libreria SKU0599561
Descrizione libro Stanford University Press, 1992. HRD. Condizione libro: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Codice libro della libreria CA-9780804716697
Descrizione libro Stanford University Press, 1992. HRD. Condizione libro: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Codice libro della libreria IP-9780804716697
Descrizione libro Stanford University Press. Hardcover. Condizione libro: New. New copy - Usually dispatched within 2 working days. Codice libro della libreria B9780804716697